From the *Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD; †iCAD, Inc, Nashua, NH; ‡Division of Cancer Treatment and Diagnosis, Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; §Imaging Physics, SAIC Frederick, Inc, National Cancer Institute-Frederick, Frederick, MD; and ∥Laboratory of Pathology, ¶Center for Interventional Oncology, and #Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Received for publication March 14, 2015; accepted July 7, 2015.
Correspondence to: Baris Turkbey, MD, Molecular Imaging Program, National Cancer Institute, 10 Center Dr, MSC 1182, Bldg 10, Room B3B85, Bethesda, MD 20892-1088 (e-mail: [email protected]).
Supported by the National Institutes of Health (NIH) Medical Research Scholars Program, a public-private partnership supported jointly by the NIH, and generous contributions to the Foundation for the NIH from Pfizer, Inc; The Doris Duke Charitable Foundation; The Alexandria Real Estate Equities, Inc; Mr and Mrs Joel S. Marcus; and the Howard Hughes Medical Institute as well as other private donors. For a complete list, please visit the Foundation Web site at http://fnih.org/work/education-training-0/medical-research-scholars-program.
